HOME >> BIOLOGY >> NEWS
Tomato packs more cancer-fighting punch

WEST LAFAYETTE, Ind. Forget the attack of the killer tomato, this is the attack of the healthy tomato: A team of scientists has developed a tomato that contains as much as three and a half time more of the cancer-fighting antioxidant lycopene.

It turns out that the antioxidant-rich tomato was a happy accident.

Scientists at Purdue University and the U.S. Department of Agriculture's Agricultural Research Service were working to develop tomatoes for food processing that were of higher quality and would ripen later.

They accomplished that, but in the process they discovered that the new tomatoes also had significantly more of the antioxidant than conventional tomatoes.

"We were quite pleasantly surprised to find the increase in lycopene," says Avtar Handa (pronounced "Honda"), professor of horticulture at Purdue.

Although increasing the nutritional value of foods is the goal of so-called second-generation biotechnology products, there have been few success stories.

"This is one of the first examples of increasing the nutritional value of food through biotechnology," Handa says. "In fact, it may be the first example of using biotechnology to increase the nutritional value of a fruit."

Co-discoverer Autar Mattoo, who heads the USDA Vegetable Laboratory, says the increase in lycopene occurred naturally in the genetically modified tomatoes. "The pattern for the accumulation was the same as in the control tomatoes," he says. "The lycopene levels increased two to 3.5 times compared to the non-engineered tomatoes."

The research was announced this week in the June issue of Nature Biotechnology.

A separate article on the research in Nature Biotechnology noted, "The findings remind us that in the 'rational' and quantitatively driven post-genomic era, serendipity still has a large part to play."

A U.S. patent application has been filed on behalf of the joint owners USD
'"/>

Contact: Steve Tally
tally@purdue.edu
765-494-9809
Purdue University
18-Jun-2002


Page: 1 2 3 4

Related biology news :

1. Tomato ripening gene could make store tomatoes tastier
2. Newly Identified Tomato Gene Appears Key To Fruit Softening
3. Molecular motor packs DNA into viruses at greater than champagne pressures, researchers report
4. Uncovering structure of cellular switch could aid design of cancer-fighting drugs
5. Researchers discover new vein of cancer-fighting agents
6. New compound could give some types of cancer the one-two punch
7. Avastin-Tarceva combo provides one-two punch against lung cancer
8. Study suggests double punch could more efficiently kill viruses
9. As bodies age, disease-fighting cells lose punch
10. Legumes found to contain starch carrying a fiber-like punch
11. One-two punch knocks out fly genes

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/8/2017)... YORK , Feb. 8, 2017 About ... individual,s voice to match it against a stored ... such as pitch, cadence, and tone are compared ... require minimal hardware installation, as most PCs already ... for different transactions. Voice recognition biometrics are most ...
(Date:2/7/2017)... MINNETONKA, Minn. , Feb. 7, 2017   ... that supports the entire spectrum of clinical research, is ... iMedNet , its innovative, highly flexible and ... iMedNet customers. iMedNet is a ... only provides Electronic Data Capture (EDC), but also delivers ...
(Date:2/3/2017)... Feb. 3, 2017 A new independent identity ... Partners, LLP (IdSP) . Designed to fill a critical ... identity market, founding partners Mark Crego and ... years just in identity expertise that span federal governments, ... leadership. The Crego-Kephart combined expertise has a common theme ...
Breaking Biology News(10 mins):
(Date:2/17/2017)... 17, 2017  Protagonist Therapeutics, Inc. (NASDAQ: PTGX) ... oral peptide drug candidates, PTG-100 and PTG-200, at ... Crohn,s and Colitis Organization (ECCO).  The ECCO congress ... from February 15 – 18, 2017. ... on Protagonist drug candidates PTG-100 and PTG-200. PTG-100, ...
(Date:2/16/2017)... GREENWICH, Conn. , Feb. 16, ... focused on venture growth investments in biotechnology and ... Josh Richardson , M.D. to Managing Director. ... companies.  He is a board observer at InfaCare ... Longitude,s investments in Aimmune Therapeutics, Akebia Therapeutics, Cadence ...
(Date:2/16/2017)... 2017   Capricor Therapeutics, Inc. (NASDAQ: ... developing first-in-class biological therapies for cardiac and other ... to terminate its license agreement with the Mayo ... Cenderitide. "Our decision to return these ... our efforts to advance our core cell and ...
(Date:2/16/2017)... Feb. 16, 2017  Dermata Therapeutics, LLC, a ... treat a variety of dermatological diseases, today announced ... financing and entered into a $5 million credit ... to use the capital for general corporate purposes ... in the treatment of serious diseases treated by ...
Breaking Biology Technology:
Cached News: